Climb Bio, Inc.
CLYM · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $87 | $93 | $44 | $47 |
| Short-Term Investments | $64 | $14 | $80 | $90 |
| Receivables | $1 | $2 | $6 | $7 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $3 | $1 | $4 | $5 |
| Total Curr. Assets | $155 | $110 | $134 | $148 |
| Property Plant & Equip (Net) | $0 | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $62 | $0 | $0 | $25 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $62 | $0 | $1 | $25 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $217 | $110 | $135 | $173 |
| Liabilities | – | – | – | – |
| Payables | $1 | $0 | $1 | $1 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $4 | $2 | $5 | $5 |
| Total Curr. Liab. | $5 | $3 | $6 | $6 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $0 | $0 | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $1 | $0 | $0 | $0 |
| Total Liabilities | $5 | $3 | $6 | $6 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$230 | -$156 | -$121 | -$76 |
| AOCI | $0 | -$0 | -$0 | -$0 |
| Other Equity | $442 | $264 | $250 | $243 |
| Total Equity | $212 | $108 | $129 | $167 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $217 | $110 | $135 | $173 |
| Net Debt | -$87 | -$93 | -$43 | -$47 |